Acrylamide

Acrylamide

SCHEMBL1417837

C=CC(N)=O.NCC(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Acrylamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.65
ALDH1A1 P00352 5/20 0.65
FGFR4 P22455 1/20 0.65
GLRA1 P23415 1/20 0.59
SLC6A9 P48067 1/20 0.59
OR51E2 Q9H255 1/20 0.59
LMNA P02545 3/20 0.42
GABRR1 P24046 5/20 0.38
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 1/20 0.37
BLM P54132 4/20 0.36
CYP2D6 P10635 3/20 0.36
KMT2A Q03164 2/20 0.36
NFKB1 P19838 2/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
MEN1 O00255 1/20 0.36
CYP2C19 P33261 1/20 0.36
GABRR2 P28476 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylamide SCHEMBL1908217 1.00 TSHR (0.65) TSHRALDH1A1FGFR4GLRA1SLC6A9
Acrylamide SCHEMBL28362017 0.85 ALDH1A1 (0.69) TSHRALDH1A1FGFR4GLRA1SLC6A9
Acrylic Acid SCHEMBL27586368 0.85 LMNA (0.62) TSHRALDH1A1FGFR4GLRA1SLC6A9
Acrylamide SCHEMBL28209083 0.84 TSHR (0.92) TSHRALDH1A1FGFR4OR51E2LMNA
Malonic Acid SCHEMBL2437426 0.82 TSHR (0.65) TSHRALDH1A1FGFR4GLRA1SLC6A9
Succinic Acid SCHEMBL28213422 0.82 TSHR (0.65) TSHRALDH1A1FGFR4OR51E2LMNA
Succinic Acid SCHEMBL28443304 0.82 TSHR (0.65) TSHRALDH1A1FGFR4OR51E2LMNA
Malonic Acid SCHEMBL27781561 0.82 TSHR (0.65) TSHRALDH1A1FGFR4GLRA1SLC6A9
Acrylamide SCHEMBL29083279 0.82 ALDH1A1 (0.65) TSHRALDH1A1FGFR4GLRA1SLC6A9
Acrylamide SCHEMBL28238685 0.82 ALDH1A1 (0.65) TSHRALDH1A1FGFR4GLRA1SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140296463-A1 POLYMERS DERIVED FROM ITACONIC ACID LUBRIZOL ADVANCED MATERIALS, INC. (US) 2014-10-02 US claimed
CN-116018141-A Salt and crystal form containing indole derivatives, and preparation method and application thereof 上海翰森生物医药科技有限公司 2023-04-25 CN disclosed
CN-109963979-A The composition of organo-silicon compound containing beta-keto carbonyl group function 瓦克化学股份公司 2019-07-02 CN disclosed
CN-106397646-B High intensity supramolecular hydrogel and its preparation method and application 天津大学 2018-06-15 CN disclosed
CN-106397646-A High-strength super-molecular hydrogel, preparation method therefor and application of high-strength super-molecular hydrogel 天津大学 2017-02-15 CN disclosed
CN-101448412-B For composition and the method for surface modification of root vegetable products MCCAIN FOODS LTD. (CA) 2016-05-04 CN disclosed
US-20140296463-A1 POLYMERS DERIVED FROM ITACONIC ACID LUBRIZOL ADVANCED MATERIALS, INC. (US) 2014-10-02 US disclosed
US-8557246-B2 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof INSTITUTO NACIONAL DE INVESTIGACIÓN Y TECNOLOGÍA AGRARIA Y ALIMENTARIA (ES) 2013-10-15 US disclosed
WO-2011082098-A1 LYSINE AND ARGININE METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER THE ROCKEFELLER UNIVERSITY (US) 2011-07-07 WO disclosed
EP-2298910-A1 FUSION PROTEIN THAT DIRECTS VACCINE ANTIGENS TO ANTIGEN-PRESENTING CELLS, AND APPLICATIONS THEREOF Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria (ES) 2011-03-23 EP disclosed
US-20110061136-A1 FUSION PROTEIN THAT DIRECTS VACCINE ANTIGENS TO ANTIGEN-PRESENTING CELLS, AND APPLICATIONS THEREOF ALTERNATIVE GENE EXPRESSION, S.L. (ES) 2011-03-10 US disclosed
CN-101970666-A Fusion protein for directing vaccine antigen to antigen presenting cell and application thereof INST NAC INVESTIGACION INIA 2011-02-09 CN disclosed
WO-2010136182-A1 METHYLGLYOXAL-SCAVENGING COMPOUNDS AND THEIR USE FOR THE PREVENTION AND TREATMENT OF PAIN AND/OR HYPERALGESIA Ruprecht-Karls-Universität Heidelberg (DE) 2010-12-02 WO disclosed
EP-2069386-A2 SHARPLY RESOLVING LABELED PROTEIN MOLECULAR WEIGHT STANDARDS Life Technologies Corporation (US) 2009-06-17 EP disclosed
CN-101448412-A Compositions and methods for surface modification of root vegetable products MCCAIN FOODS LTD (CA) 2009-06-03 CN disclosed
WO-2008042495-A2 SHARPLY RESOLVING LABELED PROTEIN MOLECULAR WEIGHT STANDARDS Life Technologies Corporation (US) 2008-04-10 WO disclosed
EP-1218743-A2 LAYERED DEVICE WITH CAPTURE REGIONS FOR CELLULAR ANALYSIS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2002-07-03 EP disclosed
WO-2001007915-A2 LAYERED DEVICE WITH CAPTURE REGIONS FOR CELLULAR ANALYSIS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH (US) 2001-02-01 WO disclosed